MAP3K3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.946340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.246790E-01
Normal-vs-Stage2
2.580200E-02
Normal-vs-Stage3
5.196500E-02
Normal-vs-Stage4
1.754360E-01
Stage1-vs-Stage2
9.562800E-01
Stage1-vs-Stage3
4.889400E-01
Stage1-vs-Stage4
8.735000E-01
Stage2-vs-Stage3
4.146200E-01
Stage2-vs-Stage4
8.816200E-01
Stage3-vs-Stage4
3.308800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.482320E-02
Normal-vs-AfricanAmerican
3.857600E-01
Normal-vs-Asian
1.988070E-02
Caucasian-vs-AfricanAmerican
2.520800E-01
Caucasian-vs-Asian
1.067810E-01
AfricanAmerican-vs-Asian
1.271770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.863570E-02
Normal-vs-Female
2.773700E-02
Male-vs-Female
2.074600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.330600E-01
Normal-vs-Age(41-60Yrs)
4.355600E-02
Normal-vs-Age(61-80Yrs)
2.014400E-02
Normal-vs-Age(81-100Yrs)
1.094310E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.590800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.028200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.534000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.874000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.613600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.382600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.589740E-02
Normal-vs-Daily Drinker
7.222600E-03
Normal-vs-Weekly Drinker
5.925900E-02
Normal-vs-Occasional Drinker
8.144600E-03
Normal-vs-Social Drinker
1.530180E-01
Non Drinker-vs-Daily Drinker
8.179600E-01
Non Drinker-vs-Weekly Drinker
3.084000E-01
Non Drinker-vs-Occasional Drinker
8.739800E-01
Non Drinker-vs-Social Drinker
1.037640E-01
Daily Drinker-vs-Weekly Drinker
3.580200E-01
Daily Drinker-vs-Occasional Drinker
9.494000E-01
Daily Drinker-vs-Social Drinker
1.232980E-01
Weekly Drinker-vs-Occasional Drinker
3.497600E-01
Weekly Drinker-vs-Social Drinker
5.671400E-01
Occasional Drinker-vs-Social Drinker
1.311210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.310000E-01
Normal-vs-Grade 2
8.795600E-01
Normal-vs-Grade 3
9.392800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.078400E-01
Grade 1-vs-Grade 3
9.190000E-01
Grade 1-vs-Grade 4
8.310000E-01
Grade 2-vs-Grade 3
3.286600E-01
Grade 2-vs-Grade 4
8.795600E-01
Grade 3-vs-Grade 4
9.392800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.226300E-02
Normal-vs-NonDiabetic
1.403610E-02
Diabetic-vs-NonDiabetic
9.904600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.664100E-02
Normal-vs-NoPancreatitis
1.615780E-02
Pancreatitis-vs-NoPancreatitis
8.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.672420E-02
Normal-vs-N1
2.523700E-02
N0-vs-N1
4.183000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.481610E-03
Normal-vs-TP53-NonMutant
8.921700E-02
TP53-Mutant-vs-TP53-NonMutant
7.055500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
